Page 9 - Pharma Sector News Today

While acute therapies account for a higher share in the Indian pharma market, the chronic segment catching up at a higher speed

Indian drugmakers outperformed multinational pharma players in the Indian Pharma Market in May, a trend that has been going on since the past 12 months.

After seeing about 80 per cent success in animal trials, a team of Indian doctors are soon set to launch human trials on the made in India 'liquid cornea' for people with corneal blindness

ISLAMABAD: The government restored the sales tax structure on drugs and pharmaceuticals on July 1st, 2022 position...

KARACHI: Based on initial analysis, the Federal Budget FY24 announced by the Finance Minister Ishaq Dar on Friday is...

The brokerage has an add call for Sun Pharma, with a price target of Rs 1,150 per stock, reflecting an upside potential of 16.5 percent from the closing price on June 8. The company is the brokerage firms top pick in the pharma sector.

Not just pharma companies, JM Financial also sees a bright future for diagnostics as well as hospital players in FY24

Despite a positive stance, Nuvama does see regulatory challenges as an overhang for the pharma industry.

Many brokerages see margin pressure and expensive valuations impacting the stock while some others are betting on branded business and a steady domestic market to provide a boost.

While most brokerages are positive on Aurobindo Pharmas strong investments in biosimilars, Pen-G, injectables and peptides, the current stock valuation remains a key concern for others.